“…However there are also other benefits described in the literature, for example better visibility on US or CT guidance (due both to the greater number of acoustic interfaces, and to the slightly larger needle size), shorter procedure time and a 15% increase in biopsy technical success [16]. As for diagnostic accuracy, our experience confirms the studies conducted so far, that calculated the positive predictive value of pretreatment SRM biopsy to be between 95 and 100%, with accuracy between 84% and 97% [10,19,20,[22][23][24][25][26] (Table 3). In our series the 2-cm cutoff approaches statistical significance for diagnostic accuracy; this is probably due to the difficulty in visualising smaller lesions with the imaging guide during biopsy, especially when the lesion is intraparenchymal; thus we believe that this could remain a valid cut-off for a prospective study on diagnostic accuracy of needle biopsy for SRM.…”